AXTI

AXTI remains in a Stage 4 decline under down-sloping EMAs, with lower highs and lower lows confirming bearish medium-term bias. Price is holding just above the 200 DMA amid extreme oversold and exhaustion conditions, making immediate selling less favorable until a decisive breakdown occurs.

• ↑Secured three-year $22M supply agreement with Coherent boosting revenue visibility.
• ↑Q1 2026 revenue rose 38.5% YoY to $26.9M; backlog exceeds $100M.
• ↓Export permit hurdles delay shipments and hinder revenue recognition.